Kombiglyze XR



Indications and Reactions:

Role Indications Reactions
Primary
Diabetes Mellitus 39.6%
Type 2 Diabetes Mellitus 39.6%
Hypertension 5.2%
Blood Glucose Increased 2.0%
Depression 1.6%
Gastrooesophageal Reflux Disease 1.6%
Hyperlipidaemia 1.6%
Anxiety 0.8%
Blood Cholesterol Increased 0.8%
Blood Glucose 0.8%
Blood Pressure 0.8%
Cardiac Disorder 0.8%
Diabetes Mellitus Inadequate Control 0.8%
Gastric Disorder 0.8%
Hypersensitivity 0.8%
Schizophrenia 0.8%
Abdominal Pain 0.4%
Back Pain 0.4%
Bipolar Disorder 0.4%
Blood Cholesterol Abnormal 0.4%
Diarrhoea 11.8%
Pancreatitis 10.3%
Drug Ineffective 6.4%
Gastrointestinal Disorder 6.1%
Rash 6.1%
Blood Glucose Increased 5.8%
Abdominal Discomfort 5.5%
Nausea 5.5%
Vomiting 5.2%
Medication Residue Present 4.5%
Medication Residue 4.2%
Pruritus 3.9%
Headache 3.6%
Dizziness 3.3%
Myalgia 3.3%
Abdominal Pain 3.0%
Malaise 3.0%
Weight Decreased 3.0%
Constipation 2.7%
Glycosylated Haemoglobin Increased 2.7%
Secondary
Diabetes Mellitus 33.3%
Type 2 Diabetes Mellitus 21.2%
Product Used For Unknown Indication 12.1%
Barrett's Oesophagus 6.1%
Gastrooesophageal Reflux Disease 6.1%
Blood Cholesterol Abnormal 3.0%
Blood Glucose Increased 3.0%
Diabetes Mellitus Inadequate Control 3.0%
Glucose Tolerance Impaired 3.0%
Glycosylated Haemoglobin Increased 3.0%
Hypercholesterolaemia 3.0%
Hypertension 3.0%
Blood Glucose Increased 10.8%
Drug Ineffective 10.8%
Vomiting 10.8%
Joint Swelling 8.1%
Pancreatitis 8.1%
Abdominal Pain Upper 5.4%
Lipase Increased 5.4%
Myalgia 5.4%
Nausea 5.4%
Bone Pain 2.7%
Burning Mouth Syndrome 2.7%
Diarrhoea 2.7%
Feeling Hot 2.7%
Haemorrhage 2.7%
Hiatus Hernia 2.7%
Incorrect Storage Of Drug 2.7%
Injection Site Swelling 2.7%
Jaundice 2.7%
Medication Error 2.7%
Medication Residue 2.7%
Concomitant
Product Used For Unknown Indication 44.0%
Type 2 Diabetes Mellitus 12.9%
Diabetes Mellitus 9.1%
Hypertension 6.2%
Pain 2.9%
Dry Eye 2.4%
Asthma 1.9%
Blood Pressure Abnormal 1.9%
Fibromyalgia 1.9%
Heart Disorder 1.9%
Prophylaxis 1.9%
Atrial Fibrillation 1.4%
Blood Cholesterol Increased 1.4%
Blood Pressure 1.4%
Bursitis 1.4%
Cardiac Disorder 1.4%
Dyspepsia 1.4%
Gastrooesophageal Reflux Disease 1.4%
Hypersensitivity 1.4%
Migraine 1.4%
Weight Decreased 15.2%
Pain 12.1%
Injection Site Haemorrhage 9.1%
Death 6.1%
Injection Site Reaction 6.1%
Swollen Tongue 6.1%
Vomiting 6.1%
Acute Respiratory Distress Syndrome 3.0%
Aphasia 3.0%
Asthenia 3.0%
Blood Glucose Increased 3.0%
Cardiac Failure 3.0%
Convulsion 3.0%
Diabetes Mellitus 3.0%
Drug Ineffective 3.0%
Drug Interaction 3.0%
Feeling Hot 3.0%
Flushing 3.0%
Herpes Simplex 3.0%
Hospitalisation 3.0%